Manufacturer profileFUJIREBIO DIAGNOSTICS, INC
IndonesiaUnited States20 products registered
VerifiedKemenkes (Ministry of Health) · official registry
20
Total Products
20
Product Names
1
Product Classes
2
Risk Classes
Regulatory footprint
Search FUJIREBIO DIAGNOSTICS, INC across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRisk classification breakdown
Distribution of products across risk classes
Kelas Resiko : B525.0% of total
Kelas Resiko : C1575.0% of total
Product class portfolio
Products organized by product class
Kelas : 2
ARCHITECT BNP Calibrators, ALINITY i BNP Calibrators, ALINITY i CA 19-9XR Controls, ARCHITECT CA 125 II Controls, ARCHITECT CA 125 II Reagent Kit ... and 15 more products in this class
20 Products
Recent registrations (20 most recent)
Most recently registered products with Ministry of Health
ARCHITECT BNP Calibrators
Oct 7, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i BNP Calibrators
Oct 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i CA 19-9XR Controls
Oct 1, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT CA 125 II Controls
Sep 27, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT CA 125 II Reagent Kit
Sep 24, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT CA 125 II Calibrators
Sep 19, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i HE4 Calibrators
Aug 4, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Tacrolimus Calibrators
Jul 9, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Tacrolimus Reagent Kit
Jul 8, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i BNP Reagent Kit
May 27, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT BNP Reagent Kit
May 21, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i Tacrolimus Reagent Kit
May 21, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i Tacrolimus Calibrators
May 20, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i Tacrolimus Whole Blood Precipitation Reagent
May 20, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT Galectin-3 Controls
May 8, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ARCHITECT Galectin-3 Calibrators
May 8, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ARCHITECT Galectin-3 Reagent Kit
May 8, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : B
ALINITY i CA 15-3 Controls
Mar 8, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ALINITY i CA 15-3 Reagent Kit
Mar 5, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
ARCHITECT CA 15-3 Calibrators
Mar 5, 2024
- Class
- Kelas : 2
- Risk Class
- Kelas Resiko : C
About this profile
FUJIREBIO DIAGNOSTICS, INC from United States is a medical device manufacturer with 20 registered products in the Indonesia Ministry of Health database through Pure Global AI's free platform. The company produces 20 unique product types across 1 product class.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.